Concepedia

Jonathan Feld

JF

Statistics

Publications

9

Citations

589

H-Index

9

Active since

2005

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Dana-Farber Cancer Institute

Albert Einstein College of Medicine

Jonathan Feld is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and medical oncology.

ORCID

Publications per year

2005–2022

9

Publications

9

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld et al. · Thrombosis Research · 2020 · 129 citations · Full text

, , +16

Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells

Aditi Shastri, Gaurav S. Choudhary, Margarida Teixeira et al. · Journal of Clinical Investigation · 2018 · 93 citations · Full text

, , +17

Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis

Jonathan Feld, Douglas Tremblay, Santiago Thibaud et al. · International Journal of Laboratory Hematology · 2020 · 93 citations · Full text

, , +12

Traumatic Injury Activates Protein Kinase B/Akt in Cultured Astrocytes: Role of Extracellular ATP and P2 Purinergic Receptors

Joseph T. Neary, Yuan Kang, Jonathan Feld · Journal of Neurotrauma · 2005 · 88 citations

, , +16

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

Jonathan Feld, Douglas Tremblay, Mikaela Dougherty et al. · HemaSphere · 2021 · 52 citations · Full text

, , +16

1–5 of 9